BRIAN LIPES: Open Payments
NPI 1629008685 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,786 in 63 payments from 22 companies in 2025. Trend: 2023 $2,141 · 2024 $407 · 2025 $1,786
Food & beverage: $1,540Education: $246
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 4 | $298 |
| Astellas Pharma US Inc | 4 | $205 |
| Janssen Biotech, Inc. | 7 | $148 |
| ABBVIE INC. | 6 | $146 |
| Eisai Inc. | 4 | $123 |
| PFIZER INC. | 6 | $118 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| Merck Sharp & Dohme LLC | 4 | $88 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| SEAGEN INC. | 1 | $78 |
Products named: OPDUALAG, Lenvima, VENCLEXTA, ULTOMIRIS, KEYTRUDA, RYBREVANT, OPDIVO, PADCEV.
Industry payments across NY — which companies pay providers there.
